Let's remember that on the 16th of May the ASX forced BOT to make a retraction regarding its antimicrobial program and the claim - which then turned out to be true -that "bacteria do not form resistance to BTX1801".
It makes sense then to delay disclosure to the ASX of any 'in-vivo/in-vitro' (?) acquired data till there's further confirmation, it's nonetheless a smart move from BOT to lodge patent applications on 'preliminary' (?) data.
In any case, re-reading the announcement from the 15th of October it becomes apparent that their synthetic cannabidiol analog program was well advanced then:
"Botanix has created a library of novel cannabidiol analogs with varying characteristics that show
properties of the natural cannabidiol molecule can be enhanced without sacrificing activity."
In a market with a track record of misinterpreting positive data as 'negative' (like with the late Phase II), BOT 's choice of playing its card close to its chest can be appreciated.
- Forums
- ASX - By Stock
- BOT - Anything but charting
Let's remember that on the 16th of May the ASX forced BOT to...
-
- There are more pages in this discussion • 10,229 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.8¢ |
Change
0.008(2.03%) |
Mkt cap ! $690.6M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.8¢ | $122.2K | 321.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 481005 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 155607 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 482800 | 0.375 |
26 | 492606 | 0.370 |
18 | 774256 | 0.365 |
14 | 221195 | 0.360 |
16 | 313757 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 148954 | 8 |
0.385 | 323059 | 7 |
0.390 | 185177 | 8 |
0.395 | 249619 | 5 |
0.400 | 199827 | 6 |
Last trade - 11.19am 10/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online